ertsfan

Einhorn's Greenlight Capital Updates Its Portfolio

Thanks.

Does All of Pfizer's Bad News Just Have To Be In by Now?

Howkim: Have you read "The Whistleblower: Confessions of a Healthcare Hitman" by Peter Rost? Rost worked for Pharmacia when PFE bought Pharmacia out. Pretty interesting book.

Pfizer: Dividend Yield Makes It a Haven in This Market

No more than the analysts cited in this and other pro-PFE drivel. Taking S&P as a random sample of one, their price target has been stair-stepping down from 30 to the current 21 at least since 2005. PFE has no pipeline, which is why they bought out Warner-Lambert et al. Their chart has been going straight down since July 2000. For 8 straight years value investors have been heralding PFE has bottomed and "now" is the time to buy (I mean, "now." I mean, "Now." I mean, "NOW"), they have been repeating the mantra of the graying of America and all things drug-related will go up, and they have been touting the dividend. And amazingly enough we still hear about their pipeline, but what significant drug have they produced recently (or even not so recently)? Viagra was approved in 1998. Are you really satisfied with a 7% dividend as your portfolio growth goal? (In comparison, Ken Heebner's CGM Focus Fund is up about 17% YTD.) What's changed about PFE since 2000? Why not force PFE to prove themselves before committing money there? Why not see if they can first hit 18 and stick? Or make them hit 19 and stick? Or, God forbid, force them to stick 20? When PFE hits 17 (then 16 then 15), will the chorus "But it's got a great dividend" make the weak share price okay?

Pfizer: Dividend Yield Makes It a Haven in This Market

With picks like this you probably won't need capital gains offsets, but PFE's great benefit is you'll be able to count on taking a wonderful capital loss when you've finally thrown in the towel.

Pfizer: Ride or Let Slide?

Not only does PFE pay a great dividend, but when you sell you'll have a great write off.

Pfizer: Low Expectations Make Great Investments

PFE should use some of their cash horde to buy some biotechs to do something about their pathetic pipeline. PFE's labs are useless. Great looking chart -- for shorting.